Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics' products treat bacterial AND viral infectious disease through a common mechanism of action in the host.
Inhibikase Therapeutics is an innovation engine developing novel strategies for treatment of bacterial and viral infectious disease. Inhibikase Therapeutics’ technology works by inhibiting human pathways used by multiple bacteria and viruses for reproduction in the patient, blocking viral and bacterial reproduction without stimulating resistance. Its products treat respiratory, CNS, liver, kidney and gastrointestinal infections.